Explain why plasmapheresis use in hypertriglyceridemia-induced pancreatitis is category III (case-by-case basis)
Describe how study monitored patients and which laboratory tests/clinical markers were used to assess progress
Understand that although plasmapheresis improves laboratory metrics, it remains unclear whether that translates to clinically significant improvement/change in disease course

Presented by: Joshua Glass (Heme/Onc Fellow, PGY-4)